Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22561829 | 0.84 | CA1 (0.31) | CA1CA2CA4CA12CA7 | |
| SCHEMBL9003976 | 0.83 | CA1 (0.33) | CA1CA2CA4CA12CA7 | |
| SCHEMBL18882779 | 0.80 | DPP4 (0.33) | DPP4 | |
| SCHEMBL9945896 | 0.80 | — | — | |
| SCHEMBL17553253 | 0.80 | — | — | |
| SCHEMBL12599608 | 0.80 | — | — | |
| SCHEMBL1996066 | 0.80 | MEN1 (0.35) | CA1CA2CA4 | |
| SCHEMBL13385366 | 0.80 | BCL2 (0.33) | — | |
| SCHEMBL20223463 | 0.80 | BCL2 (0.33) | — | |
| SCHEMBL13377140 | 0.80 | GABRA1 (0.31) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265055-A1 | STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS | OXFORD FINANCE LLC | 2023-08-24 | — | — | US | disclosed |
| US-9795953-B2 | Organometallic catalysts | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2017-10-24 | — | — | US | disclosed |
| US-20160214098-A1 | NOVEL ORGANOMETALLIC CATALYSTS | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2016-07-28 | — | — | US | disclosed |
| US-9303100-B2 | Organometallic catalysts | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2016-04-05 | — | — | US | disclosed |
| US-20150025212-A1 | NOVEL ORGANOMETALLIC CATALYSTS | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2015-01-22 | — | — | US | disclosed |
| US-20120149693-A1 | THERAPEUTIC COMPOUNDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149693-A1 | THERAPEUTIC COMPOUNDS | HTR2C, GRK2, GRK3 | CA1 4827/4885CA2 3510/4885CA4 4858/4885 |
| US-20160214098-A1 | NOVEL ORGANOMETALLIC CATALYSTS | ZKSCAN2, ZC3HAV1L, ZRANB2 | CA1 1759/4885CA2 1613/4885CA4 1008/4885 |
| US-20230265055-A1 | STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS | STAT5B, STAT5A, STAT3 | CA1 4704/4885CA2 4486/4885CA4 4763/4885 |
| US-20150025212-A1 | NOVEL ORGANOMETALLIC CATALYSTS | ZKSCAN2, ZC3HAV1L, ZRANB2 | CA1 1759/4885CA2 1613/4885CA4 1008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.